Contact Investors Careers Support Search English Model-informed Drug Development Data and Informatics Regulatory and Access Resources Company Home / Data and Informatics / CODEx & Clinical Trial Outcomes Databases CODEx and Clinical Trial Outcomes Databases Quantify your competitive edge Gain faster time to insight Along the development path of a compound, you must make critical decisions to ensure drug approval and market success. Success depends not only on the drug’s performance, but also on the competitive landscape, requiring reliable assessments—now and for the future—of your competition. Publicly available clinical trial data represent an underutilized source of information. When properly extracted and analyzed, clinical trial data provide a great source of information to support drug development decisions. We have created an extensive collection of over 45 Clinical Trial Outcomes Databases covering a wide range of therapeutic areas that capture high-quality public source data on drug efficacy and safety, drug, disease and trial characteristics, trial design, and the competitive landscape to inform critical decisions. Go to the CODEx platform We have a dozen databases in Immunology, including our latest one for COVID-19. Go to Immunology databases The Clinical Trial Outcomes Database for Glaucoma has data from over 140 trials with 30,000+ patients. Learn more The Alzheimer Disease database includes clinical safety and efficacy information on symptomatic drugs as well as Abeta drugs. Download brochure Analysis-ready clinical trial outcomes data Certara’s Clinical Outcomes Databases include information for marketed drugs as well as drugs in development; data source includes journal publications, conference posters, regulatory reviews, etc. They leverage valuable public clinical trial data to provide key drug development insights for: Comparative efficacy/ safety Scaling of endpoints and subpopulations Trial design optimization Commercial viability Get a demo Visualize, explore, analyze, and communicate Our intuitive, interactive, web-based graphical interface unlocks the value and richness of public and proprietary clinical outcome data. This interface allows you to easily visualize, explore, analyze, and communicate the content of the databases to a broad audience within pharmaceutical companies. Easily select data subsets with built-in filters View interactive tables and graphs for meta-analysis Access database updates in a timely manner Get custom database content based on your needs Try CODEx for Free More than 40 therapeutic areas Cardiovascular and metabolic: AF stroke prevention, chronic kidney disease, heart failure, NASH, obesity, secondary stroke prevention, T1DM & T2DM… Immunology: Crohn’s Disease, multiple sclerosis, COVID-19, psoriasis, rheumatoid arthritis, lupus, ulcerative colitis… Oncology: Metastatic breast cancer, multiple myeloma, non-small cell lung cancer, Non-Hodgkin’s lymphoma, small cell lung cancer, PD1 – solid tumors… CNS, pain & other: Alzheimer’s, AMD, asthma, chronic pain, cystic fibrosis, glaucoma, HBV, HCV, idiopathic pulmonary, major depression, migraine, narcolepsy, osteoporosis, schizophrenia… Contact Certara Jaap Mandema, PhD Chief Innovation Officer Jaap’s research interests are applying modeling and simulation to optimize treatment strategies, trial designs, and drug development decision-making. He is the world’s leading expert on model-based meta analysis and has published extensively and received several awards for his academic contributions. Resources How MBMA Can Help You Make Smarter Drug Development Decisions BLOG Model-based Meta-analysis: An Innovative Methodology Comes of Age WHITE PAPER Quantify Chronic Kidney Disease Clinical Outcomes Database BROCHURE Building an MBMA Framework to Support Developing New Neuropathic Pain Drugs ON-DEMAND WEBINAR Services Anonymization and Redaction Cell and Gene Therapy Clinical Pharmacology Clinical Pharmacology Study Stewardship Complex Biologics Decision Analytics and Modeling Document Quality and Management Drug Development and Regulatory Strategy eCTD Authoring Templates French SNDS Data Access and Analysis See more Software PHOENIX™ PK/PD PLATFORM v 8.3 Phoenix WinNonlin Simcyp PBPK Simulator Quantitative Systems Pharmacology D360 Scientific Informatics Platform Integral Data Repository BaseCase Value Communication Software CODEx & Clinical Trial Outcomes Databases GlobalSubmit eCTD Submissions Software Phoenix WinNonlin Validation Suite See more Resources Articles Blogs Best of Blogs 2020 Case Studies Certara in the Press Certara University Certification Program Conferences Knowledge Base Podcasts See more Company Careers Certara Code of Conduct Contact Certara Leadership Legal Locations News Our Story Partners Privacy Center See more English Privacy Center Legal Copyright © 2020 Certara, USA. All rights reserved. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Accept All Cookies